References
- Kampman K, Jarvis M. American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use. J Addict Med. 2015;9(5):358–367.
- Mattick RP, Breen C, Kimber J, et al. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;(2):CD002207.
- Larochelle MR, Bernson D, Land T, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann Intern Med. 2018;169(3):137–145.
- Strayer RJ, Hawk K, Hayes BD, et al. Management of opioid use disorder in the emergency department: a white paper prepared for the American Academy of Emergency Medicine. J Emerg Med. 2020;58(3):522–546.
- Houry D, Adams J. Emergency physicians and opioid overdoses: a call to aid. Ann Emerg Med. 2019;74(3):436–438.
- The Case for Medication-Assisted Treatment: MAT can help people with opioid use disorders, but few have access [press release]. Philadelphia (PA): The PEW Charitable Trusts; February 1, 2017.
- Jones CM, Campopiano M, Baldwin G, et al. National and state treatment need and capacity for opioid agonist medication-assisted treatment. Am J Public Health. 2015;105(8):e55–e63.
- Rosenblatt RA, Andrilla CH, Catlin M, et al. Geographic and specialty distribution of US physicians trained to treat opioid use disorder. Ann Fam Med. 2015;13(1):23–26.
- Haukoos JS, Lyons MS, Rothman RE. The evolving landscape of HIV screening in the emergency department. Ann Emerg Med. 2018;72(1):54–56.
- Ahmad I, Ali PA, Rehman S, et al. Intimate partner violence screening in emergency department: a rapid review of the literature. J Clin Nurs. 2017;26(21–22):3271–3285.
- Boudreaux ED, Camargo CA, Jr., Arias SA, et al. Improving suicide risk screening and detection in the emergency department. Am J Prev Med. 2016;50(4):445–453.
- Anderson ES, Pfeil SK, Deering LJ, et al. High-impact hepatitis C virus testing for injection drug users in an urban ED. Am J Emerg Med. 2016;34(6):1108–1111.
- D’Onofrio G, O’Connor PG, Pantalon MV, et al. Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. JAMA. 2015;313(16):1636–1644.
- Dunkley CA, Carpenter JE, Murray BP, et al. Retrospective review of a novel approach to buprenorphine induction in the emergency department. J Emerg Med. 2019;57(2):181–186.
- Kaucher KA, Caruso EH, Sungar G, et al. Evaluation of an emergency department buprenorphine induction and medication-assisted treatment referral program. Am J Emerg Med. 2020;38(2):300–304.
- Kelly T, Hoppe JA, Zuckerman M, et al. A novel social work approach to emergency department buprenorphine induction and warm hand-off to community providers. Am J Emerg Med. 2020;38(6):1286–1290.
- Martin A, Baugh J, Chavez T, et al. Clinician experience of nudges to increase ED OUD treatment. Am J Emerg Med. 2020. [published online ahead of print]. doi:10.1016/j.ajem.2020.03.050
- Wax PM, Stolbach AI, Schwarz ES, et al. ACMT position statement: buprenorphine administration in the emergency department. J Med Toxicol. 2019;15(3):215–216.
- Research Offers New Insights Into the Opioid Crisis [press release]. Irving (TX): American College of Emergency Physicians; October 30, 2017.
- Im DD, Chary A, Condella AL, et al. Emergency department clinicians’ attitudes toward opioid use disorder and emergency department-initiated buprenorphine treatment: a mixed-methods study. West J Emerg Med. 2020;21(2):261–271.
- Lowenstein M, Kilaru A, Perrone J, et al. Barriers and facilitators for emergency department initiation of buprenorphine: a physician survey. Am J Emerg Med. 2019;37(9):1787–1790.
- Guerrero E, Ober AJ, Howard DL, et al. Organizational factors associated with practitioners’ support for treatment of opioid use disorder in the emergency department. Addict Behav. 2020;102:106197.
- Palombi LC, St Hill CA, Lipsky MS, et al. A scoping review of opioid misuse in the rural United States. Ann Epidemiol. 2018;28(9):641–652.
- Knudsen HK, Abraham AJ, Oser CB. Barriers to the implementation of medication-assisted treatment for substance use disorders: the importance of funding policies and medical infrastructure. Eval Program Plann. 2011;34(4):375–381.
- Schwarz ES, Laes JR, Wiegand TJ. A new way forward in the emergency department. J Med Toxicol. 2019;15(4):220–222.
- Martin A, Kunzler N, Nakagawa J, et al. Get waivered: a resident-driven campaign to address the opioid overdose crisis. Ann Emerg Med. 2019;74(5):691–696.
- Gold KJ, Andrew LB, Goldman EB, et al. “I would never want to have a mental health diagnosis on my record”: a survey of female physicians on mental health diagnosis, treatment, and reporting. Gen Hosp Psychiatry. 2016;43:51–57.
- Battarbee AN, Aliaga S, Boggess KA. Management of diabetic women with threatened preterm birth: a survey of Maternal-Fetal Medicine providers. J Matern Fetal Neonatal Med. 2020;33(17):2941–2949.
- Campbell RM, Venn TJ, Anderson NM. Cost and performance tradeoffs between mail and internet survey modes in a nonmarket valuation study. J Environ Manage. 2018;210:316–327.
- VanGeest JB, Johnson TP, Welch VL. Methodologies for improving response rates in surveys of physicians: a systematic review. Eval Health Prof. 2007;30(4):303–321.